Skip to content
AnalystLens

Cencora, Inc. 8-K Report, Material Agreement (Dec 10, 2024)

Reports
Material Agreements·Financial Events·Regulation FD+2
Filing Date
Filed December 10, 2024
Period End
December 9, 2024
Security
COR
In the record · 2016–202610-K1010-Q338-K184

COR filed 10 annual reports (10-K), 33 quarterly reports (10-Q) and 184 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Nov ’18Nov ’18
  2. Material agreement8-K · Oct ’20Oct ’20
  3. Material agreement8-K · Dec ’22Dec ’22
  4. Leadership change8-K · Sep ’26Sep ’26

Summary

Summary of the 8-K filed December 10, 2024. Cited figures are marked; the original filing is the authoritative source.

Cencora, Inc. (COR) closed a $1.8 billiona underwritten senior notes offering on December 9, 2024, consisting of $500 million of 4.625% Senior Notes due December 2027, $600 million of 4.850% Senior Notes due December 2029, and $700 million of 5.150% Senior Notes due February 2035.

The notes are unsecured, rank equally with the company's existing unsecured senior debt, and are structurally subordinated to all liabilities of its subsidiaries. The indentures contain customary covenants limiting liens, sale-leaseback transactions, and mergers or asset sales, along with standard events of default. The proceeds are earmarked primarily to finance the majority of the proposed acquisition of Retina Consultants of America, with the remainder for general corporate purposes.

The company had earlier secured $3.3 billionb in bridge commitments for the deal; a $1.5 billion senior unsecured term loan was entered into on November 26, 2024, and the remaining $1.8 billion of bridge commitments was terminated upon receipt of the bond proceeds. This refinancing replaces short-term bridge funding with longer-dated fixed-rate debt, reducing near-term refinancing risk.

Importantly, the notes carry a special mandatory redemption at 101% of principal if the Retina Consultants acquisition is not completed by August 5, 2025 or is terminated beforehand. Investors should therefore monitor the deal's closing status, as the financing structure would unwind in that scenario, and should weigh the incremental leverage and roughly $1.8 billionc of new interest-bearing debt against the strategic benefits of the acquisition in Cencora's specialty and ophthalmology-related retina care business.

Key Highlights

  1. Issued $1.8 billion of senior unsecured notes in three tranches: $500M 4.625% due 2027, $600M 4.850% due 2029, and $700M 5.150% due 2035.
  2. Proceeds will primarily fund the majority of the Retina Consultants of America acquisition, with the balance for general corporate purposes.
  3. Remaining $1.8 billion of bridge financing commitments terminated on December 9, 2024, after the bond proceeds were received; a $1.5 billion term loan was previously entered into on November 26, 2024.
  4. Notes require redemption at 101% of principal if the Retina Consultants acquisition is not completed by August 5, 2025 or is terminated earlier, creating a contingent refinancing obligation.
  5. Notes are unsecured and rank pari passu with existing senior unsecured debt but are structurally subordinated to subsidiary liabilities, including trade payables.
  6. Indentures include covenants restricting liens, sale-leaseback transactions, and mergers or sales of substantially all assets, plus customary events of default.
  7. Make-whole call provisions apply before November 2027, November 2029, and November 2034 for the respective tranches, with par redemption thereafter.

Frequently Asked Questions

  1. Why did Cencora issue $1.8 billion of senior notes?

    The company issued the notes primarily to finance the majority of its proposed acquisition of Retina Consultants of America, with the remainder used for general corporate purposes. The issuance replaced the bridge financing committed for the deal.

  2. What happens to the notes if the Retina Consultants acquisition falls through?

    If the acquisition is not completed by August 5, 2025, or is terminated before that date, Cencora must redeem all of the notes in full at 101% of principal plus accrued interest. This protects bondholders but would require the company to repay the debt early.

  3. How does this debt affect Cencora's credit profile?

    The filing does not state rating agency actions. The $1.8 billion of new unsecured debt increases total leverage, and the notes are structurally subordinated to subsidiary obligations. Investors should evaluate pro forma leverage after the acquisition closes and the company's ability to deleverage.

  4. What protections do noteholders have?

    The indentures restrict the company and its restricted subsidiaries from creating liens and engaging in sale-leaseback transactions, and limit mergers or sales of substantially all assets. Events of default include nonpayment, covenant breaches, cross-defaults on other debt, unpaid final judgments, and bankruptcy events.

  5. When do interest payments and maturities occur?

    The 2027 and 2029 notes pay interest semiannually on June 15 and December 15, starting June 15, 2025, and mature December 15, 2027 and 2029 respectively. The 2035 notes pay interest on February 15 and August 15, starting February 15, 2025, and mature February 15, 2035.